Margex, one of the top crypto derivatives exchanges, has upgraded its copy trading platform with a new one-click trading feature. Now, users can automatically follow top traders and start earning from their winning trades seamlessly.For beginners, busy crypto traders, and anyone else who can benefit from copy trading, Margex’s one-click follow feature allows copy traders […] The post Margex Adds New One-Click Feature For Simplified Copy Trading appeared first on Cryptonews.Margex, one of the top crypto derivatives exchanges, has upgraded its copy trading platform with a new one-click trading feature. Now, users can automatically follow top traders and start earning from their winning trades seamlessly.For beginners, busy crypto traders, and anyone else who can benefit from copy trading, Margex’s one-click follow feature allows copy traders […] The post Margex Adds New One-Click Feature For Simplified Copy Trading appeared first on Cryptonews.
Margex Adds New One-Click Feature For Simplified Copy Trading
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com
Margex, one of the top crypto derivatives exchanges, has upgraded its copy trading platform with a new one-click trading feature. Now, users can automatically follow top traders and start earning from their winning trades seamlessly.For beginners, busy crypto traders, and anyone else who can benefit from copy trading, Margex’s one-click follow feature allows copy traders […]
The post Margex Adds New One-Click Feature For Simplified Copy Trading appeared first on Cryptonews.
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
You May Also Like
Immutep (IMM) Stock Doubles on FDA Orphan Drug Win for Rare Cancer Drug
TLDR Immutep stock jumped over 101% on Wednesday after receiving FDA Orphan Drug Designation for eftilagimod alfa (efti). The designation covers soft tissue sarcoma
Share
Coincentral2026/04/15 20:09
XRP flashes golden cross signal: Is $5 next?
The post XRP flashes golden cross signal: Is $5 next? appeared on BitcoinEthereumNews.com. As XRP continues to consolidate, its technical structure is flashing
Share
BitcoinEthereumNews2026/04/15 20:34
Immutep (IMM) Shares Soar 101% Following FDA Orphan Drug Status for Cancer Therapy
Immutep (IMM) stock soared 101% after FDA granted Orphan Drug Designation for eftilagimod alfa in soft tissue sarcoma. Market exclusivity & tax benefits await.
Share
Blockonomi2026/04/15 20:19
